Evidence map›Paper›PMID 40655277›Full record

ReviewFood science and biotechnology2025

Trends in the recognition system and safety assessments of novel foods in Korea.

Jeong A Han, Chaeyeong Kim, Ju Hyun Sung, Hyojin Chang, Sangryeol Ryu

Abstract readReview
In one paragraph

Review in Food science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeong A Han *Division of Novel Food, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju, Chungbuk 28159 Republic of Korea.ORCID 0000-0002-8488-192X
Chaeyeong Kim *Division of Novel Food, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju, Chungbuk 28159 Republic of Korea.
Ju Hyun SungDivision of Novel Food, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju, Chungbuk 28159 Republic of Korea.
Hyojin ChangDivision of Novel Food, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju, Chungbuk 28159 Republic of Korea.
Sangryeol RyuDepartment Agricultural Biotechnology, Department of Food and Animal Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826 Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examines the recognition systems and safety assessments of novel food ingredients in Korea and other countries, providing insights for developing future safety criteria. It analyzes the recognition status from 2010, when Korea introduced its novel ingredient recognition system, through 2023, reviewing regulations and guidelines from seven major countries, including the Generally Recognized as Safe (GRAS) of the Food and Drug Safety in the USA, the European Food Safety Authority in the European Union, Food Standards Australia New Zealand in the Australia/New Zealand, Health Canada in Canada, Singapore Food Agency in Singapore, and China's National Health Commission in China. The study revealed that most novel food applications in Korea were plant-based, followed by microbial ingredients. By 2023, 72 novel food ingredients had been approved in Korea under the Temporary Standards and Specifications for Foods. This research highlights the growing global interest in novel foods, such as plant-based proteins and microbial fermentation products. It emphasizes the need for Korea to align its safety assessments with internationally coordinated standards. Supplementary Information: The online version contains supplementary material available at 10.1007/s10068-025-01836-9.

Indexed as

Food standardGRASNovel foodRecognition systemSafety assessment

Identifiers

PMID40655277
PMCPMC12240882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.